Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemia.
Bhoomi Mehrotra(St. Francis Hospital), Maria G. Pallavicini(University of California, San Francisco), Susan K. Atwater(University of California, San Francisco), Kris Kavanau(University of California, San Francisco), Dan H. Moore(Oregon Health & Science University), Cheryl L. Willman(Mayo Clinic), Hervé Avet‐Loiseau(Institut universitaire du cancer de Toulouse Oncopole), Marilyn L. Slovak(City Of Hope National Medical Center), David R. Head(University of Southern California), Tracy I. George(University of Utah)
Cited by 96
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k